NCT Number: NCT06235151
Phase: PHASE3
Trial Summary: This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very h – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Curium US LLC
Acronym: Solar-Stage
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives